FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLS

MDR report key: 1020248 · Received March 26, 2008

Report

Report Number
9680658-2008-00080
Event Type
Malfunction
Date Received
March 26, 2008
Date of Event
February 26, 2008
Report Date
February 26, 2008
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
LOM
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE FOLLOWING STATEMENT APPEARS IN THE INSTRUCTIONS FOR USE FOR VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLS: "WARNING: POTENTIALLY INFECTIOUS MATERIAL HUMAN BLOOD PRODUCTS PROVIDED AS COMPONENTS OF THIS PACK HAVE BEEN OBTAINED FROM DONORS WHO WERE TESTED INDIVIDUALLY AND WHO WERE FOUND TO BE NEGATIVE FOR HEPATITIS B SURFACE ANTIGEN AND FOR ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS (HIV 1+2) AND HEPATITIS C VIRUS (HCV), USING APPROVED METHODS (ENZYME IMMUNOASSAYS). TREAT AS IF CAPABLE OF TRANSMITTING INFECTION. CARE SHOULD BE TAKE WHEN HANDLING MATERIAL OF HUMAN ORIGIN. ALL SAMPLES SHOULD BE CONSIDERED POTENTIALLY INFECTIOUS. NO TEST METHOD CAN OFFER COMPLETE ASSURANCE THAT HEPATITIS B VIRUS, HCV, HIV 1+2, OR OTHER INFECTIOUS AGENTS ARE ABSENT. HANDLING OF SAMPLES AND ASSAY COMPONENTS, THEIR USE, STORAGE, AND SOLID AND LIQUID WASTE DISPOSAL SHOULD BE IN ACCORDANCE WITH THE PROCEDURES DEFINED BY THE APPROPRIATE NATIONAL BIOHAZARD GUIDELINE OR REGULATION (E.G. NCCLS GUIDELINE M29). NO TREATMENT HAS BEEN INITIATED. PROPER PERSONAL PROTECTIVE EQUIPMENT WAS NOT BEING WORN AT THE TIME OF THE EVENT. THE CAUSE OF THE EVENT WAS USER ERROR.

Description of Event or Problem · 1

A CUSTOMER SPLASHED CONTROL FOR ANTI-HBS INTO THEIR EYES. THE FLUID CONTAINS HUMAN BLOOD PRODUCTS. THERE WAS NO IMMEDIATE HARM TO THE SUBJECT AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLS IN VITRO DIAGNOSTIC CONTROL LOM ORTHO-CLINICAL DIAGNOSTICS NA 270

Patients

Seq Age Sex Outcome Treatment
1